Cullin 3 mutant causing familial hyperkalemic hypertension lacks normal activity in the kidney

Yujiro Maeoka, Ryan J. Cornelius, Mohammed Z. Ferdaus, Avika Sharma, Luan T. Nguyen, James A. McCormick

American Journal of Physiology-Renal Physiology · 2022 · 11 citations · 32 references

DOIFull text

Open access

Concepts

Abstract

CUL3 mutation (CUL3-Δ9) causes familial hyperkalemic hypertension (FHHt) by reducing adaptor KLHL3, impairing substrate WNK4 degradation. Whether CUL3-Δ9 affects other targets in kidneys remains unclear. We found that CUL3-Δ9 cannot degrade two CUL3 targets, cyclin E and nuclear factor erythroid-2-related factor 2 (NRF2; using a surrogate marker NQO1), or rescue injury or polyuria caused by Cul3 disruption. In an FHHt model, CUL3-Δ9 impaired NRF2 degradation without reduction of its adaptor KEAP1. Our data provide additional insights into CUL3-Δ9 function in the kidney.

References

32